OR WAIT null SECS
July 02, 2017
Pharma company consolidation and outsourcing led to a de-emphasis of manufacturing and reduced investment in new technologies and facilities.
Advancements in cell culture and protein technology have opened the door for new therapies.
June 26, 2017
Fagron Sterile Services has voluntarily recalled three lots of Succinylcholine Chloride 20mg/mL 5mL syringe to the hospital/clinic level.
June 21, 2017
The need for flexibility and higher quality are driving advances in parenteral manufacturing and fill/finish equipment.
June 19, 2017
The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance.
June 14, 2017
FDA sent a warning letter to drug compounder DCA, Inc. dba Beacon Prescriptions for failing to ensure sanitary conditions.
June 07, 2017
USP describes analytical and microbiology testing required for different types of pharmaceutical water.
May 09, 2017
FDA sent a warning letter to Pharmaceutic Labs, LLC for deficiencies in producing sterile drugs.
May 02, 2017
Robotic fill/finish systems reduce human intervention, improve flexibility, and allow more gentle handling of containers.
May 01, 2017
The type of water for pharmaceutical use is determined by USP testing.